SBIR/STTR Research Award

NOVEL OPTICAL PROBE FOR ORAL AND DENTAL TISSUE SCREENING

Award identifier c3250c1893e2a749f86eb1bda1f569e0e6e89bbe98dd35033097acf7a2e148a8Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Biotex, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
SUH7H6LEZTS2
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION: Currently under development is a novel optical probe for non-invasive characterization and monitoring of the biochemical and morphological changes in oral cavity epithelium leading to dysplasia and ultimately to invasive squamous cell carcinoma. Oral squamous cell carcinoma is a condition, which will kill approximately half of patients afflicted within five years of diagnosis and may leave surviving patients with severe aesthetic or functional compromises. Approximately 31,000 Americans develop oral cancer each year. Oral cancer progresses through a series of morphologic changes, which, if detected and treated early, can vastly improve prognosis and survival. Clinicians in the oral and Dental fields play an important role in early detection of oral cancer, and the current application seeks to develop a tool to aid these clinicians in accurate screening and diagnosis. During a previous Phase 1 SBIR effort, a fluorescence image guided optical coherence tomography (FIG-OCT) probe, capable of simultaneously acquiring and co-registering tissue autofluorescence and optical coherence tomography (OCT) images, was designed and built. Fluorescence imaging provides a highly sensitive and rapid means for oral cavity screening, while the ability of OCT to elucidate high-resolution sub-surface morphological features leads to a superior diagnostic technique with higher specificity than autofluorescence imaging alone. In a hamster model of oral cancer, it was successfully demonstrated that FIG-OCT resulted in a rapid and accurate technique for oral cancer screening. The current Phase 1 application presents plan to adapt this instrument into a form, which can be used, for preliminary clinical investigation in humans. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

60 SBIR/STTR records share this UEI (1997–2025). Reported award amounts total $24,544,336. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, Environmental Protection Agency, Department of Defense, National Science Foundation, Department of Agriculture, National Aeronautics and Space Administration

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.